← Home / Twist Bioscience Corp (TWST)
Stock Analysis

Twist Bioscience Corp (TWST)

TWST
TWST · Healthcare • Diagnostics & Research
150.04 -1.07%
Track TWST in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when TWST price is:
52W Range Position
99%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-08-26 21:17 UTC
WOI Investment Thesis
Constructive
Watch confirmation and structural levels before acting.
⚖️
✓
Fundamentals
Strong / Negative / Pressured / Strong
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
No reliable structural support level is currently available.
Not available
↗
Break Above
No reliable confirmation level is currently available.
Not available
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
Recent Company Events
SEC VERIFIED
Latest material filings
AUG
5
●
Material Agreement
HIGH
TWST material agreement
On August 4, 2026, Twist Bioscience Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co.
8-K Filing • SEC EDGAR
AUG
3
●
Financial Results
HIGH
TWST reports financial results
On August 3, 2026, Twist Bioscience Corporation (the “ Company ”) issued a press release announcing its financial results for the quarter ended June 30, 2026.
8-K Filing • SEC EDGAR
MAY
4
●
Financial Results
HIGH
Twist Bioscience Reports Fiscal Second Quarter 2026 Financial Results
— Record revenue of $110.7 million in 2QFY26 ; Increase of more than 19% over $92.8 million in 2QFY25; 13th consecutive quarter of sequential growth — — Gross margin of 51.6% in 2QFY26 ; Improvement of approximately 2 margin points versus 2QFY25 — — Revenue guidance raised to $442-$447M; Reiterating Q4 FY26 Adj EBIT...
8-K Filing • SEC EDGAR
What's Driving TWST?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
◆ Business quality is mixed
Revenue growth is strong. Profitability is negative. Cash generation is pressured. Balance-sheet quality is strong.
Full Analysis Workspace
Technical Signal
No Active Technical Setup
•
No qualified technical setup is currently active.
RSI(14)
68.3
Price Chart
TWST — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-25
Spec
Speculative premium
Valuation is very demanding relative to current fundamentals; expectations are high.
Market Cap
$8.8B
Company size
EV
$8.8B
Debt-adjusted value
P/S
20.4
Very high
P/B
19.8
Premium
EV/Sales
20.3
Very high
FCF Yield
-0.73%
Cash return
Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Strong
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Strong
💵 Revenue
118.38M
↗ Strong
📈 Net Income
-35.05M
↘ Negative
🧮 EPS (Basic)
-0.56
↘ Negative
Twist Bioscience Corp
Healthcare • Diagnostics & Research
You Might Also Like